Featured Research

from universities, journals, and other organizations

Compound That Mimics Insulin Might Lead To Pill For Diabetes

Date:
May 7, 1999
Source:
American Association For The Advancement Of Science
Summary:
Diabetics may someday pop a pill to control their disease, now that scientists have discovered a compound that might make such a pill effective. This new substance, whose discovery is reported in the 7 May issue of Science, appears to mimic the effects of insulin, at least in mice--but, unlike insulin, it can be swallowed instead of injected.

Washington DC - Diabetics may someday pop a pill to control their disease, now that scientists have discovered a compound that might make such a pill effective. This new substance, whose discovery is reported in the 7 May issue of Science, appears to mimic the effects of insulin, at least in mice--but, unlike insulin, it can be swallowed instead of injected. A pill developed from this substance could be a welcome alternative to the insulin injections or rigorous lifestyle monitoring that are currently part of a diabetic's daily life.

Related Articles


Diabetes occurs when the body's cells are unable to absorb enough blood sugar, or glucose, to fuel their activities. To access this energy supply, cells need assistance from the hormone insulin, which kicks off a complex series of steps inside the cells that allows them to store and use glucose. This cascade of events doesn't occur-or occurs poorly-in diabetics, either because their bodies don't produce insulin (type I diabetes), or because they are resistant to its effects (type II). An oral drug that could trigger the same set of reactions in place of insulin could therefore be a boon for people with either form of the disease.

In order to avoid or delay the serious complications their disease can cause, diabetics must carefully control their blood sugar levels-currently a high-maintenance task. People with the early-onset and more severe type I diabetes need as many as four daily injections of insulin. And people with type II diabetes, who are usually over 40 or overweight, must carefully regulate their diet, weight, and physical activity. About 10% of the population in the Western world develops some degree of type II diabetes, so a pill that made the disease easier to manage could have a widespread benefit.

The research team, whose members are from the US, Spain, and Sweden, screened over 50,000 different compounds to see if any of them might perform as a stand-in for insulin. The compound would have to bind to the cell's insulin receptor and activate a certain enzyme as the first step in the cascade of events that would lead to the sequestering of glucose in the cells. In essence, the compound would need to flip the same biochemical switch in the cell that insulin does. To see if any of the thousands of candidate molecules were up to the task, the scientists incubated the various substances with cultured cells engineered to have an abundance of insulin receptors. Then they tested these mixtures to find out whether the enzyme that initiates the insulin "signal" had been activated.

Insulin is a peptide molecule, a chain of amino acids whose bonds are vulnerable to the digestive acids in the stomach. In their screening tests, Bei Zhang of Merck Research Laboratories in Rahway, New Jersey and her colleagues were looking specifically at nonpeptide molecules, which can be absorbed into the bloodstream after being swallowed in a pill form. The most promising candidate was L-783,281, a compound whose prosaic name belies its origins from a fungus on a leaf collected in what is now the Democratic Republic of Congo. Remarkably, in a variety of tests, this tiny compound mimicked the activity of the much larger insulin molecule.

First the scientists experimented with the compound on cultured cells to determine that it docked onto the correct receptor and stimulated the same response as insulin. Then they administered the new compound by mouth to two different strains of mice that are standard animal models for human diabetes and found that it significantly lowered the mice's blood sugar.

The development of a pill that can be used in human diabetics will require much more research. Scientists must now tinker with the molecule to see if they can maximize its effectiveness while keeping it safe. Zhang and her colleagues are optimistic that other yet-unknown compounds besides L-783,281 might also be able to effectively imitate insulin. Further research could then lead to the development of a new suite of anti-diabetic drugs.


Story Source:

The above story is based on materials provided by American Association For The Advancement Of Science. Note: Materials may be edited for content and length.


Cite This Page:

American Association For The Advancement Of Science. "Compound That Mimics Insulin Might Lead To Pill For Diabetes." ScienceDaily. ScienceDaily, 7 May 1999. <www.sciencedaily.com/releases/1999/05/990507071958.htm>.
American Association For The Advancement Of Science. (1999, May 7). Compound That Mimics Insulin Might Lead To Pill For Diabetes. ScienceDaily. Retrieved November 29, 2014 from www.sciencedaily.com/releases/1999/05/990507071958.htm
American Association For The Advancement Of Science. "Compound That Mimics Insulin Might Lead To Pill For Diabetes." ScienceDaily. www.sciencedaily.com/releases/1999/05/990507071958.htm (accessed November 29, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Saturday, November 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Rural India's Low-Cost Sanitary Pad Revolution

Rural India's Low-Cost Sanitary Pad Revolution

AFP (Nov. 28, 2014) — One man hopes his invention -– a machine that produces cheap sanitary pads –- will help empower Indian women. Duration: 01:51 Video provided by AFP
Powered by NewsLook.com
Research on Bats Could Help Develop Drugs Against Ebola

Research on Bats Could Help Develop Drugs Against Ebola

AFP (Nov. 28, 2014) — In Africa's only biosafety level 4 laboratory, scientists have been carrying out experiments on bats to understand how virus like Ebola are being transmitted, and how some of them resist to it. Duration: 01:18 Video provided by AFP
Powered by NewsLook.com
WHO Says Male Ebola Survivors Should Abstain From Sex

WHO Says Male Ebola Survivors Should Abstain From Sex

Newsy (Nov. 28, 2014) — WHO cites four studies that say Ebola can still be detected in semen up to 82 days after the onset of symptoms. Video provided by Newsy
Powered by NewsLook.com
Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins